Soliris (eculizumab) is effective for treating relapses in patients with atypical hemolytic uremic syndrome, even in the presence…
Articles by Aisha I Abdullah PhD
A child with atypical hemolytic uremic syndrome (aHUS) caused by a mutation in…
Soliris (eculizumab) can be used successfully to treat patients with pregnancy-related atypical hemolytic uremic syndrome (aHUS) complicated by kidney,…
A diagnostic process combining genetic, clinical, and patient inquiry data may help in the identification and categorization of patients with…
Soliris (eculizumab) can effectively treat patients with both atypical hemolytic uremic syndrome (aHUS)…
The first reported instance of a COVID-19 infection triggering an…